Suppr超能文献

基于谷胱甘肽响应的可降解纳米药物用于干预葡萄糖代谢并诱导铁死亡以增强磁热抗肿瘤治疗

GSH-responsive degradable nanodrug for glucose metabolism intervention and induction of ferroptosis to enhance magnetothermal anti-tumor therapy.

机构信息

Department of Biomedical Engineering, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 61173, Sichuan, People's Republic of China.

Precision Medicine Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.

出版信息

J Nanobiotechnology. 2024 Apr 3;22(1):147. doi: 10.1186/s12951-024-02425-4.

Abstract

The challenges associated with activating ferroptosis for cancer therapy primarily arise from obstacles related to redox and iron homeostasis, which hinder the susceptibility of tumor cells to ferroptosis. However, the specific mechanisms of ferroptosis resistance, especially those intertwined with abnormal metabolic processes within tumor cells, have been consistently underestimated. In response, we present an innovative glutathione-responsive magnetocaloric therapy nanodrug termed LFMP. LFMP consists of lonidamine (LND) loaded into PEG-modified magnetic nanoparticles with a FeO core and coated with disulfide bonds-bridged mesoporous silica shells. This nanodrug is designed to induce an accelerated ferroptosis-activating state in tumor cells by disrupting homeostasis. Under the dual effects of alternating magnetic fields and high concentrations of glutathione in the tumor microenvironment, LFMP undergoes disintegration, releasing drugs. LND intervenes in cell metabolism by inhibiting glycolysis, ultimately enhancing iron death and leading to synthetic glutathione consumption. The disulfide bonds play a pivotal role in disrupting intracellular redox homeostasis by depleting glutathione and inactivating glutathione peroxidase 4 (GPX4), synergizing with LND to enhance the sensitivity of tumor cells to ferroptosis. This process intensifies oxidative stress, further impairing redox homeostasis. Furthermore, LFMP exacerbates mitochondrial dysfunction, triggering ROS formation and lactate buildup in cancer cells, resulting in increased acidity and subsequent tumor cell death. Importantly, LFMP significantly suppresses tumor cell proliferation with minimal side effects both in vitro and in vivo, exhibiting satisfactory T2-weighted MR imaging properties. In conclusion, this magnetic hyperthermia-based nanomedicine strategy presents a promising and innovative approach for antitumor therapy.

摘要

激活铁死亡用于癌症治疗所面临的挑战主要源于与氧化还原和铁稳态相关的障碍,这些障碍阻碍了肿瘤细胞对铁死亡的敏感性。然而,铁死亡抵抗的具体机制,特别是那些与肿瘤细胞内异常代谢过程交织在一起的机制,一直被低估。有鉴于此,我们提出了一种名为 LFMP 的创新型谷胱甘肽响应磁热疗纳米药物。LFMP 由负载 lonidamine(LND)的聚乙二醇修饰的具有 FeO 核的磁性纳米颗粒以及用二硫键桥联的介孔硅壳组成。这种纳米药物旨在通过破坏平衡来诱导肿瘤细胞加速铁死亡激活状态。在交变磁场和肿瘤微环境中高浓度谷胱甘肽的双重作用下,LFMP 发生崩解,释放药物。LND 通过抑制糖酵解干预细胞代谢,最终增强铁死亡并导致合成谷胱甘肽消耗。二硫键通过耗尽谷胱甘肽和使谷胱甘肽过氧化物酶 4(GPX4)失活来在细胞内氧化还原平衡中发挥关键作用,与 LND 协同作用增强肿瘤细胞对铁死亡的敏感性。这一过程加剧了氧化应激,进一步破坏了氧化还原平衡。此外,LFMP 加剧了线粒体功能障碍,导致 ROS 形成和乳酸在癌细胞中积累,导致酸度增加,随后肿瘤细胞死亡。重要的是,LFMP 在体外和体内均能显著抑制肿瘤细胞增殖,且副作用极小,表现出令人满意的 T2 加权磁共振成像特性。总之,这种基于磁热疗的纳米医学策略为抗肿瘤治疗提供了一种有前途的创新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ecf0/11321096/0ac1c7cee4c6/12951_2024_2425_Sch1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验